Alibaba and Didi Add $93 Billion Rally for Chinese Stocks in US
Alibaba Group Holding Ltd.$Alibaba(BABA)$ and Didi Global Inc. $DiDi Global Inc.(DIDI)$ rallied for a subsequent day, adding $93 billion in value to U.S. listed Chinese stocks as fears of potential delistings facilitated. The Nasdaq Golden Dragon China Index bounced 7.4% Monday, adding to Friday’s move in the wake of Beijing regulators distributed revised draft rules rejecting necessities that on-site inspections ought to be basically directed by China. Alibaba rose 6.6% and Didi climbed 6.4%, while JD.com Inc.$JD.com(JD)$ progressed 7.1%. Pinduoduo Inc.$Pinduoduo Inc.(PDD)$ , Bilibili Inc. and iQiyi $iQiyi Inc.(IQ)$ Inc. were among the top gainers, moving somewhere around 16% each.
“For now, investors are erasing the regulatory risk premium which is helping both markets and sentiment recover,” said Olivier d’Assier, head of APAC applied research at Qontigo. While the regulatory risks is receding, there still leaves a lot of macro risk which is yet unknown, as well as geopolitics, he added.
The advance in American depositary receipts tracked a 5.4% gain in Hong Kong’s Hang Seng Tech Index, the sharpest in two weeks. China was closed for a holiday.
Beijing’s move could potentially remove a key hurdle to U.S. regulators gaining full access to auditing reports for Chinese companies listed in New York, ending a long-running dispute over data sharing. Last week, Bloomberg News had reported that Beijing is drafting a framework that will allow a majority of Chinese firms to keep their listings.
While the latest statement appears to show Beijing is more constructive on this, some remain cautious until the final resolution comes through.
“We believe this is an important step in clarifying China’s stance on the audit dispute,” Morgan Stanley equity strategists led by Laura Wang said in an April 3 note. “We maintain our view that the likelihood of a final agreement being reached over the ADR audit dispute is now higher.”
“I am expecting more twists going forward, as the U.S. and China go back and forth on this,” said Henry Guo, an analyst at M Science LLC. “The regulation overhang for Chinese ADRs should remain in the near future and investors are cautious about investing in them as regulation-related risks are totally out of their control.”
SEC chief last week dialed down speculation of an imminent deal with Chinese counterpart on the delisting issue.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
Oh